Clover Health Securities Litigation
This settlement is closed to new claims. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Clover Health and its executives allegedly violated federal securities laws by making false and misleading statements about legal or regulatory violations, regulatory investigations, sources of growth, use of proprietary software, compliance with accounting principles, and SEC regulations. The defendants agreed to settle for $22 million without admitting wrongdoing.
Do you qualify?
All persons or entities who purchased or otherwise acquired Clover securities (including warrants) between October 6, 2020, and February 3, 2021, inclusive. Excluded are Clover, the individual defendants, company officers and directors, their families, and anyone who properly excluded themselves.
How to file
Contact the Claims Administrator, JND Legal Administration, by calling 1-877-381-0387, emailing info@CloverHealthSecuritiesLitigation.com, or mailing to Clover Health Securities Litigation, c/o JND Legal Administration, PO Box 91462, Seattle, WA 98111. A claim form can be obtained from the settlement website.
Common questions
- How much does the Clover Health Securities Litigation pay?
- The total settlement fund is $22M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
- Is the Clover Health Securities Litigation notice real, or a scam?
- JND Legal Administration is the settlement administrator for this case. Claims are filed at cloverhealthsecuritieslitigation.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- When will payments from the Clover Health Securities Litigation be sent?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for October 2, 2023; no payments can be issued before a settlement receives final approval.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Tattooed Chef Securities Settlement
Tattooed Chef, Inc. faced a securities lawsuit alleging that purchasers of the company's common stock were damaged. The defendant has agreed to settle all claims in the action for $4,750,000 in cash without admitting wrongdoing.
Estée Lauder Securities Settlement
Estée Lauder is settling securities litigation relating to alleged damages to investors who purchased or acquired publicly traded common stock of The Estée Lauder Companies Inc. during the class period. The defendant has not admitted wrongdoing in this settlement.
E-Commerce China Dangdang Securities Settlement
E-Commerce China Dangdang, Inc. was involved in a take-private transaction (merger) that closed on September 20, 2016. Shareholders who held American Depositary Shares during the Class Period claim they were harmed by undisclosed information related to the Company's take-private transaction. The defendant has agreed to settle these securities claims without admitting wrongdoing.
Evolv Technologies Holdings Securities Settlement
Investors purchased publicly traded common stock of Evolv Technologies Holdings Inc. during a specific period and are entitled to compensation from a securities class action settlement. The page does not explicitly state what wrongdoing Evolv allegedly committed.